# A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

> **NCT06817382** · PHASE1 · RECRUITING · sponsor: **Insmed Gene Therapy LLC** · enrollment: 12 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **GENETIC:** INS1201

## Key facts

- **NCT ID:** NCT06817382
- **Lead sponsor:** Insmed Gene Therapy LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-22
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06817382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06817382, "A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06817382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*